Skip to main content

Test Price

2,800 AED

✅ Home Collection Available

ENPP1 Gene Cole Disease Genetic Test in UAE | 2,800 AED | 2026 DHA Guidelines

تحليل جين ENPP1 لمرض كول بتقنية التسلسل الجيني (NGS) في الإمارات | 2,800 درهم | معتمد من هيئة الصحة بدبي

ISO 9001:2015 Certified (INT/EGQ/2509DA/3139)

✔️ Accuracy Guarantee:

99.9% Diagnostic Sensitivity via ISO-accredited next‑generation sequencing. Our facility’s dual‑run verification protocol eliminates false positives in ENPP1 gene analysis.

✔️ Premium Logistics:

Paid hospital‑grade home collection with ISO‑certified cold‑chain transport and VIP mobile phlebotomy. Whole blood, extracted DNA, or a single drop on an FTA card accepted.

✔️ Clinical Guidance:

Post‑test telephonic clinical guidance by DHA‑licensed genetic consultants, with results interpreted in the context of Cole disease and differential diagnoses.

✔️ Insurance:

Direct billing verification via WhatsApp +971 54 548 8731 – we coordinate with all major UAE medical networks.

الملخص التنفيذي بالعربية:

يوفر فحص جين ENPP1 لمرض كول دقة تشخيصية تبلغ 99.9% وفق معايير ISO. نقدم خدمة سحب العينات المنزلية المدفوعة عبر نظام نقل مبرد معتمد، ومتابعة طبية هاتفية بعد النتيجة. يمكنكم التحقق من التغطية التأمينية مباشرة عبر واتساب: +971 54 548 8731.

Overview

The ENPP1 NGS test fully sequences the ENPP1 gene to detect pathogenic variants responsible for Cole disease (palmoplantar keratoderma with leukoplakia). This single‑tube test replaces multi‑step Sanger sequencing, delivering a comprehensive report in 3‑4 weeks with clinical interpretation.

يقوم هذا الفحص بتحليل كامل جين ENPP1 للكشف عن الطفرات المسببة لمرض كول، وهو بديل دقيق وسريع عن التسلسل التقليدي.

Feature Our Test (ENPP1 NGS) Closest Alternative (Sanger Sequencing ENPP1)
Precision >99.9% sensitivity for all coding regions & splice sites; ULPA‑verified SOP High specificity for targeted amplicons, but fails to detect deep intronic or regulatory variants
Method Next‑Generation Sequencing (Illumina NovaSeq) with advanced bioinformatics Capillary electrophoresis‑based Sanger of selected exons
Speed 3–4 weeks from sample receipt 6–8 weeks (sequential exon walking)

Clinical Insight & Safety Protocol

“As a DHA‑licensed clinical pathologist, I emphasize that an ENPP1 genetic diagnosis must always be correlated with the dermatological phenotype and family history. A positive result confirms Cole disease and allows early screening for potential leukoplakia complications, but it does not replace regular dermatology follow‑up. Please consult your physician before making any treatment decisions based on this test.”

— Dr. PRABHAKAR REDDY, DHA License No. 61713011

⚠️ Medication Warning

Do not discontinue any prescribed medication or topical therapy without consulting your treating physician. Abrubt cessation of keratolytic or immunomodulatory agents may aggravate skin lesions.

🚨 Patient Safety: Exclusion Criteria & Emergency Red Flags

  • Exclusion criteria: Patients unable to provide informed consent; genetic testing of minors without parental/guardian consent per UAE CDS Law 2026; severe bleeding disorders (e.g., hemophilia with factor level <1%) that preclude blood draw; active skin infection at the venipuncture site.
  • Emergency red flags after home collection: If you experience excessive bleeding that does not stop after 10 minutes of pressure, signs of infection (redness, pus, fever), or anaphylaxis (difficulty breathing, swelling), seek immediate emergency care.

Patient FAQ & Clinical Guidance

Q: What does a positive ENPP1 test mean for my skin condition? (Arabic included)

A: A positive result confirms a pathogenic mutation in ENPP1, establishing a molecular diagnosis of Cole disease with palmoplantar keratoderma and possible oral leukoplakia.

ج: تؤكد النتيجة الإيجابية وجود طفرة مرضية في جين ENPP1، مما يثبت التشخيص الجزيئي لمرض كول المصحوب بتقرن الجلد الراحي الأخمصي والطلوان الفموي المحتمل.

Q: How should I prepare for the blood collection? (Arabic included)

A: No fasting is required; however, you must complete a pre‑test genetic counselling session and provide a detailed three‑generation family pedigree of Cole disease symptoms.

ج: لا يشترط الصيام، لكن يجب حضور جلسة استشارة وراثية قبل الفحص وتقديم شجرة عائلية مفصلة لأعراض مرض كول على ثلاثة أجيال.

Q: Will my insurance cover the 2,800 AED cost? (Arabic included)

A: Most UAE medical insurance plans with genetic testing riders cover the; we verify coverage upfront via WhatsApp +971 54 548 8731 and provide direct electronic billing.

ج: تغطي معظم خطط التأمين الصحي في الإمارات التي تتضمن فحوصات جينية هذه التكلفة؛ نتحقق من التغطية مسبقًا عبر واتساب +971 54 548 8731 ونوفر الفوترة الإلكترونية المباشرة.

This service complies with Federal Decree‑Law No. 41 of 2024 (Art. 87) on Genetic Testing, UAE PDPL for data privacy, and CDS Law 2026 protections for minors. Laboratory facility licensed by MOHAP (License: 9834453). ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139).

ICD‑10‑CM 2026 codes applicable: Q82.8 (Other specified congenital malformations of skin), Z15.89 (Genetic susceptibility to other disease), Z13.79 (Encounter for screening for genetic disease). LOINC: 98349‑2 (ENPP1 gene mutations detected).

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians